154 related articles for article (PubMed ID: 37823706)
1. Blood-brain barrier permeability is associated with different neuroinflammatory profiles in Alzheimer's disease.
Bruno M; Bonomi CG; Ricci F; Di Donna MG; Mercuri NB; Koch G; Martorana A; Motta C
Eur J Neurol; 2024 Jan; 31(1):e16095. PubMed ID: 37823706
[TBL] [Abstract][Full Text] [Related]
2. Effect of Vascular Risk Factors on Blood-Brain Barrier and Cerebrospinal Fluid Biomarkers Along the Alzheimer's Disease Continuum: A Retrospective Observational Study.
Ricci F; Martorana A; Bonomi CG; Serafini C; Mercuri NB; Koch G; Motta C
J Alzheimers Dis; 2024; 97(2):599-607. PubMed ID: 38160356
[TBL] [Abstract][Full Text] [Related]
3. Associations of CSF PDGFRβ With Aging, Blood-Brain Barrier Damage, Neuroinflammation, and Alzheimer Disease Pathologic Changes.
Cicognola C; Mattsson-Carlgren N; van Westen D; Zetterberg H; Blennow K; Palmqvist S; Ahmadi K; Strandberg O; Stomrud E; Janelidze S; Hansson O
Neurology; 2023 Jul; 101(1):e30-e39. PubMed ID: 37137722
[TBL] [Abstract][Full Text] [Related]
4. TNF-α and IL-1β Modulate Blood-Brain Barrier Permeability and Decrease Amyloid-β Peptide Efflux in a Human Blood-Brain Barrier Model.
Versele R; Sevin E; Gosselet F; Fenart L; Candela P
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142143
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer's disease but not Lewy body dementias.
Chai YL; Lee JH; Chong JR; Ballard C; Francis PT; Kennedy BK; Arumugam TV; Chen CP; Aarsland D; Lai MKP
J Neuroinflammation; 2023 May; 20(1):111. PubMed ID: 37158957
[TBL] [Abstract][Full Text] [Related]
6. Blood-brain barrier damage associates with glia-related cytokines in the cerebrospinal fluid of patients with Multiple Sclerosis.
Puthenparampil M; Marin A; Zanotelli G; Mauceri VA; De Napoli F; Gaggiola M; Miscioscia A; Ponzano M; Bovis F; Perini P; Rinaldi F; Molon B; Gallo P
Mult Scler Relat Disord; 2024 Feb; 82():105403. PubMed ID: 38184910
[TBL] [Abstract][Full Text] [Related]
7. Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer's disease.
Aksnes M; Aass HCD; Tiiman A; Edwin TH; Terenius L; Bogdanović N; Vukojević V; Knapskog AB
Transl Neurodegener; 2021 Jun; 10(1):18. PubMed ID: 34099032
[TBL] [Abstract][Full Text] [Related]
8. Interplay between the catecholaminergic enzymatic axis and neurodegeneration/neuroinflammation processes in the Alzheimer's disease continuum.
Motta C; Assogna M; Bonomi CG; Di Lorenzo F; Nuccetelli M; Mercuri NB; Koch G; Martorana A
Eur J Neurol; 2023 Apr; 30(4):839-848. PubMed ID: 36692274
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease pathology: pathways between chronic vascular risk factors and blood-brain barrier dysfunction in a cohort of patients with different types of dementia.
Gan J; Yang X; Zhang G; Li X; Liu S; Zhang W; Ji Y
Front Aging Neurosci; 2023; 15():1088140. PubMed ID: 37213537
[TBL] [Abstract][Full Text] [Related]
10. Blood-CSF-barrier permeability in tuberculous meningitis and its association with clinical, MRI and inflammatory cytokines.
Shukla R; Kalita J; Haldar R; Misra UK
J Neuroimmunol; 2022 Nov; 372():577954. PubMed ID: 36075158
[TBL] [Abstract][Full Text] [Related]
11. Proinflammatory and anti-inflammatory cytokines in the CSF of patients with Alzheimer's disease and their correlation with cognitive decline.
Taipa R; das Neves SP; Sousa AL; Fernandes J; Pinto C; Correia AP; Santos E; Pinto PS; Carneiro P; Costa P; Santos D; Alonso I; Palha J; Marques F; Cavaco S; Sousa N
Neurobiol Aging; 2019 Apr; 76():125-132. PubMed ID: 30711675
[TBL] [Abstract][Full Text] [Related]
12. Concordant and Discordant Cerebrospinal Fluid and Plasma Cytokine and Chemokine Responses in Mild Cognitive Impairment and Early-Stage Alzheimer's Disease.
de la Monte SM; Tong M; Hapel AJ
Biomedicines; 2023 Aug; 11(9):. PubMed ID: 37760836
[TBL] [Abstract][Full Text] [Related]
13. Serum Amyloidogenic Nanoplaques and Cytokines in Alzheimer's Disease: Pilot Study in a Small Naturalistic Memory Clinic Cohort.
Aksnes M; Aass HCD; Tiiman A; Terenius L; Bogdanović N; Vukojević V; Knapskog AB
J Alzheimers Dis; 2022; 86(3):1459-1470. PubMed ID: 35213378
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer's disease.
Pillai JA; Bena J; Bekris L; Kodur N; Kasumov T; Leverenz JB; Kashyap SR;
Alzheimers Res Ther; 2023 Mar; 15(1):54. PubMed ID: 36927447
[TBL] [Abstract][Full Text] [Related]
15. Impact of blood-brain barrier disruption on newly diagnosed neuromyelitis optica spectrum disorder symptoms and prognosis.
Liang S; Qin Q; Tang Y; Liao W; Yang Y; He J; Li L
Ann Palliat Med; 2020 Mar; 9(2):324-330. PubMed ID: 32268769
[TBL] [Abstract][Full Text] [Related]
16. Assessment of blood-brain barrier integrity and neuroinflammation in preeclampsia.
Burwick RM; Togioka BM; Speranza RJ; Gaffney JE; Roberts VHJ; Frias AE; Rincón M
Am J Obstet Gynecol; 2019 Sep; 221(3):269.e1-269.e8. PubMed ID: 31229428
[TBL] [Abstract][Full Text] [Related]
17. Associations Between CSF Markers of Inflammation, White Matter Lesions, and Cognitive Decline in Individuals Without Dementia.
Gertje EC; Janelidze S; van Westen D; Cullen N; Stomrud E; Palmqvist S; Hansson O; Mattsson-Carlgren N
Neurology; 2023 Apr; 100(17):e1812-e1824. PubMed ID: 36882326
[TBL] [Abstract][Full Text] [Related]
18. Plasma and cerebrospinal fluid inflammation and the blood-brain barrier in older surgical patients: the Role of Inflammation after Surgery for Elders (RISE) study.
Vasunilashorn SM; Ngo LH; Dillon ST; Fong TG; Carlyle BC; Kivisäkk P; Trombetta BA; Vlassakov KV; Kunze LJ; Arnold SE; Xie Z; Inouye SK; Libermann TA; Marcantonio ER;
J Neuroinflammation; 2021 Apr; 18(1):103. PubMed ID: 33931093
[TBL] [Abstract][Full Text] [Related]
19. Associations Between Intrathecal Levels of Vitamin D, Cytokines, and Core Biomarkers of Alzheimer's Disease: A Cross-Sectional Study.
Soares JZ; Valeur J; Šaltytė Benth J; Knapskog AB; Selbæk G; Bogdanovic N; Pettersen R
J Alzheimers Dis; 2022; 89(3):825-834. PubMed ID: 35938253
[TBL] [Abstract][Full Text] [Related]
20. Blood-Cerebrospinal Fluid Barrier Gradients in Mild Cognitive Impairment and Alzheimer's Disease: Relationship to Inflammatory Cytokines and Chemokines.
Ott BR; Jones RN; Daiello LA; de la Monte SM; Stopa EG; Johanson CE; Denby C; Grammas P
Front Aging Neurosci; 2018; 10():245. PubMed ID: 30186149
[No Abstract] [Full Text] [Related]
[Next] [New Search]
